Physician profile
Rahul Bose
NPI 1205044633
$11,940.75
in general payments reported to CMS, 2019-2025
46 companies · $1,995 in 2025
The $1,995 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $401 · 2021: $1,167 · 2022: $2,376 · 2023: $1,933 · 2024: $2,352 · 2025: $1,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,931 · Travel and Lodging: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,930.89 |
| Travel and Lodging | $348.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,066.76 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Ekosonic, Latitude Communicator Power Supply |
| Abbott Laboratories | $1,699.01 | 2019-2025 | Triclip, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $1,228.75 | 2021-2025 | Corevalve Evolut R, Kyphon Express II Kyphopak Tray, Turbohawk |
| Siemens Medical Solutions USA, INC. | $604.25 | 2024-2025 | Artis Q Floor, Artis Q Ceiling, Artis Pheno |
| Abiomed | $581.67 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $580.83 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $489.72 | 2022-2024 | Carto 3, Na |
| Biotronik INC. | $338.55 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $317.25 | 2019-2025 | |
| Novo Nordisk INC | $283.91 | 2022-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $282.90 | 2021-2024 | Verquvo |
| Philips North America LLC | $272.71 | 2021-2024 | (5153) Azurion 5 M20 Gc, (P84) Igt Devices Systems |
| Amgen INC. | $268.42 | 2021-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $238.82 | 2020 | |
| Acist Medical Systems, INC. | $189.98 | 2021-2024 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.96 | 2019-2024 | Lifevest |
| Cardiva Medical, INC. | $133.62 | 2024-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| E.R. Squibb & Sons, L.L.C. | $114.58 | 2024-2025 | Eliquis |
| Edwards Lifesciences Corporation | $111.82 | 2024 | Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $84.20 | 2021-2022 | |
| Inari Medical, INC. | $82.67 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $82.19 | 2022 | |
| Impulse Dynamics (USA) INC. | $70.17 | 2022-2023 | Optimizer |
| Amarin Pharma, INC. | $62.90 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.61 | 2019-2022 | |
| Scpharmaceuticals INC. | $52.02 | 2023-2025 | |
| Atricure, INC. | $43.02 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Kiniksa Pharmaceuticals International, Plc | $40.68 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $40.00 | 2021-2023 | Nexletol |
| Cvrx, INC. | $38.53 | 2022-2023 | Barostim Neo System |
| Reflow Medical INC | $34.24 | 2025 | |
| Surmodics, INC. | $31.32 | 2022 | |
| Tactile Systems Technology INC | $30.55 | 2021 | |
| Baxter Healthcare | $28.86 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Chiesi USA, INC. | $26.01 | 2021-2022 | |
| Shockwave Medical, INC | $24.50 | 2022 | |
| Inspire Medical Systems, INC. | $23.36 | 2025 | Inspire |
| Bsn Medical INC | $21.65 | 2022 | |
| Ge Healthcare | $18.19 | 2023 | |
| Bard Peripheral Vascular, INC. | $17.06 | 2024 | Denali Vena Cava Filter |
| Davol INC. | $15.09 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.53 | 2025 | Jardiance |
| Altathera Pharmaceuticals LLC | $13.38 | 2025 | Sotalol Hydrochloride |
| Thrombolex, INC. | $6.50 | 2024 | Bashir Endovascular Catheter |
| Cashflow Solutions, LLC | $6.01 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Bose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.